Status:
COMPLETED
Recreational Futsal for Controlled Hypertension
Lead Sponsor:
University Institute of Maia
Collaborating Sponsors:
University of Southern Denmark
Conditions:
Hypertension,Essential
Hypertension
Eligibility:
MALE
35-60 years
Phase:
NA
Brief Summary
Arterial hypertension (HT) was the leading global contributor for premature deaths in 2015. Its treatment includes medication and lifestyle changes, namely diet and regular exercise, which has shown t...
Detailed Description
Statistical analysis: The efficacy of the intervention will be assessed by comparing the differences between groups at follow-up, adjusted for the outcome baseline values, systolic blood pressure, ma...
Eligibility Criteria
Inclusion
- Medicated controlled hypertension, with habitual SBP below 140 mmHg and DBP below 90 mmHg;
- Males with 35-60 years;
- Not being engaged in regular and supervised physical exercise in the last 6 months;
- Medical clearance;
- Vaccinated against SARS-COV-2.
Exclusion
- Cardiovascular disease (heart failure), cerebrovascular disease, advanced retinopathy or kidney failure;
- Resistant hypertension;
- History of cardiovascular event.
Key Trial Info
Start Date :
November 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05185297
Start Date
November 17 2021
End Date
December 19 2022
Last Update
February 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maia
Maia, Portugal